75.15000 USD
1.085
1.46%
Last update Dec 12, 3:59 PM EST
Market closed
Day range
72.65000
75.24000
Previous close
74.065002
Open
73.83000
Access this stock data via API
Subscribe
BridgeBio Pharma Inc.
75.15
1.08
1.46%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 221.9M 9.3M 77.6M 69.7M
Cost of revenue 3.9M 2.4M 3.4M 3.1M
Gross profit 218.0M 6.9M 74.2M 66.6M
Operating expense
Research & development 506.5M 455.7M 399.5M 451.0M
Selling general and admin 288.9M 150.6M 143.2M 192.2M
Other operating expenses
Operating income -577.4M -599.4M -468.4M -576.6M
Non operating interest income
Income 17.2M 18.0M 7.5M 1.1M
Expense 99.3M 81.3M 80.4M 46.8M
Other income expense 117.2M 9.4M 56.7M 35.8M
Pretax income -542.2M -653.3M -484.7M -586.5M
Tax provision 1.2M
Net income -543.3M -653.3M -484.7M -586.5M
Basic EPS -2.9 -4.0 -3.3 -3.9
Diluted EPS -2.9 -4.0 -3.3 -3.9
Basic average shares 186.1M 162.8M 147.5M 144.4M
Diluted average shares 186.1M 162.8M 147.5M 144.4M
EBITDA -581.1M -574.6M -339.2M -569.7M
Net income from continuing op. -543.3M -653.3M -484.7M -586.5M
Minority interests 7.6M 10.0M 3.5M 23.9M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 5 hours 27 minutes

22:32
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).